Actions and Detail Panel
Consumer consultation: Review of Chaperones to protect patients
Thu. 3 November 2016, 5:30 pm – 7:30 pm AEDT
Independent review of chaperones to protect patients
Would you like the chance to give face-to-face feedback to Prof Ron Paterson in an informal evening session just for consumers? This is an opportunity to discuss what consumers think about the use of mandated chaperones to protect patients when doctors are being investigated for sexual misconduct.
You do not need to have had specific experience with chaperones or with sexual misconduct by doctors to attend. However, it is important that you have a broad understanding of the consumer and carer perspective on appropriate actions to assure the safety of patients.
Ron is particularly keen to hear the consumer perspective on these issues.
Light refreshments will be served. Participants will receive a voucher for their time and expertise.
In August of this year, the Australian Health Practitioner Regulation Agency (AHPRA) and the Medical Board of Australia announced they had commissioned a review on the use of chaperones to protect patients. The independent review is being done by Prof Paterson, an international expert on patients’ rights, complaints, healthcare quality and the regulation of health professions.
This evening session will be a relatively open format, but in case you’re interested in reading the Terms of Reference for the review, they can be viewed here. The call for written submissions has closed, but to give you some background and help you determine if you’d like to attend, the written consultation questions are below. The evening session will not be limited to these questions.
- Do you think chaperone conditions are an effective measure to protect patients, and why?
- If chaperone conditions are appropriate in some circumstances, what steps do you think need to be taken to ensure patients are protected and adequately informed?
- In what circumstances do you think chaperone conditions are not appropriate, and why?
- Can you suggest an alternative regulatory measure to protect patients while allegations of sexual misconduct are investigated?
For more information, please contact Susan Biggar at (03) 9664 9342 or email email@example.com